VYNE Therapeutics Inc. - VYNE
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 02, 2026 | CHIEF LEGAL OFFICER AND GC | F | D | 4,007.0 | 0.5975 | 2,394.18 | 121,898.0 | View | |
| Apr 02, 2026 | CHIEF SCIENTIFIC OFFICER | F | D | 2,876.0 | 0.5975 | 1,718.41 | 112,363.0 | View | |
| Apr 02, 2026 | CHIEF FINANCIAL OFFICER | F | D | 4,007.0 | 0.5975 | 2,394.18 | 99,788.0 | View | |
| Apr 02, 2026 | PRESIDENT AND CEO | F | D | 14,232.0 | 0.5975 | 8,503.62 | 401,976.0 | View | |
| Jan 05, 2026 | PRESIDENT AND CEO | F | D | 12,684.0 | 0.5801 | 7,357.99 | 416,208.0 | View | |
| Jan 05, 2026 | CHIEF FINANCIAL OFFICER | F | D | 7,858.0 | 0.5801 | 4,558.43 | 103,795.0 | View | |
| Jan 05, 2026 | CHIEF SCIENTIFIC OFFICER | F | D | 2,448.0 | 0.5801 | 1,420.08 | 115,239.0 | View | |
| Jan 05, 2026 | CHIEF LEGAL OFFICER AND GC | F | D | 3,579.0 | 0.5801 | 2,076.18 | 125,905.0 | View | |
| Dec 15, 2025 | — | A | A | 20,000.0 | 0.0 | 0.0 | 20,000.0 | View | |
| Dec 15, 2025 | — | A | A | 20,000.0 | 0.0 | 0.0 | 20,000.0 | View | |
| Dec 15, 2025 | — | A | A | 20,000.0 | 0.0 | 0.0 | 20,000.0 | View | |
| Dec 15, 2025 | — | A | A | 20,000.0 | 0.0 | 0.0 | 20,000.0 | View |